Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Association of GLP-1 Receptor Agonist Use With Risk of Suicide
- Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by OCT
- Potential Signals for Suicidal and Self-Injurious Adverse Drug Reactions Associated With Semaglutide Use
- Perioperative Management of Patients Receiving DOACs
- HbA1c Time in Range and Dementia in Older Adults With Diabetes
- Association of Intracranial Atherosclerotic Disease With Incident Dementia
- Blood Biomarkers to Detect Alzheimer's Disease in Primary and Secondary Care Settings
- Effects of Sleep Patterns on Risk of Chronic Disease
- Nirsevimab and Hospitalization for RSV Bronchiolitis
- GLP-1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes